Abstract
Neuroblastoma is the most common cancer among infants, suggesting an etiologic role for prenatal factors. In this case-cohort study, neuroblastoma cases (n = 529) diagnosed between 1985 and 2001 were identified from the New York State Cancer Registry and were matched to the electronic birth records for 1983–2001 from New York State and New York City. Controls (n = 12,010) were selected from the same birth cohorts. Analysis was stratified by age at diagnosis, with one to six months (younger infants), seven to 18 months (older infants), and older than 18 months (older children) analyzed separately. Perinatal exposure data was obtained from the birth certificates. No risk factors were identified to be consistently associated with risk across all three age groups. Generally, more risk factors were identified as associated with neuroblastoma among younger infants relative to older ages, including high birth weight, heavier maternal gestational weight gain, maternal hypertension, older maternal age, ultrasound, and respiratory distress. Among older infants, low birth weight was associated with increased risk while heavier maternal gestational weight gain was protective. In the oldest age group, first born status, primary cesarean delivery, prolonged labor and premature rupture of the membranes were associated with increased risk.
References
Maris JM, Denny CT (2002) Focus on embryonal malignancies. Cancer Cell 2:447–450. doi:10.1016/S1535-6108(02)00206-4
Nakagawara A, Zaizen Y, Ikeda K et al (1991) Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas. Cancer 68:2037–2044. doi:10.1002/1097-0142(19911101)68:9<2037::AID-CNCR2820680932>3.0.CO;2-C
Suita S, Stephen L (2002) Gans overseas lecture. Mass screening for neuroblastoma in Japan: lessons learned and future directions. J Pediatr Surg 37:949–954. doi:10.1053/jpsu.2002.33814
Bunin GR (2004) Nongenetic causes of childhood cancers: evidence from international variation, time trends, and risk factor studies. Toxicol Appl Pharmacol 199:91–103. doi:10.1016/j.taap.2003.12.028
London WB, Boni L, Simon T et al (2005) The role of age in neuroblastoma risk stratification: the German, Italian, and children’s oncology group perspectives. Cancer Lett 228:257–266. doi:10.1016/j.canlet.2004.12.054
Schmidt ML, Lal A, Seeger RC et al (2005) Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children’s Cancer Group Study. J Clin Oncol 23:6474–6480. doi:10.1200/JCO.2005.05.183
London WB, Castleberry RP, Matthay KK et al (2005) Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children’s Oncology Group. J Clin Oncol 23:6459–6465. doi:10.1200/JCO.2005.05.571
Nakagawara A, Ohira M (2004) Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model. Cancer Lett 204:213–224. doi:10.1016/S0304-3835(03)00457-9
Haase GM, Perez C, Atkinson JB (1999) Current aspects of biology, risk assessment, and treatment of neuroblastoma. Semin Surg Oncol 16:91–104. doi:10.1002/(SICI)1098-2388(199903)16:2<91::AID-SSU3>3.0.CO;2-1
Brodeur GM, Look AT, Shimada H et al (2001) Biological aspects of neuroblastomas identified by mass screening in Quebec. Med Pediatr Oncol 36:157–159. doi:10.1002/1096-911X(20010101)36:1<157::AID-MPO1038>3.0.CO;2-F
Kaneko Y, Kanda N, Maseki N et al (1990) Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study. J Clin Oncol 8:2005–2013
Schilling FH, Spix C, Berthold F et al (2003) Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany*1. Cancer Lett 197:19–28. doi:10.1016/S0304-3835(03)00077-6
Kerbl R, Urban CE, Ambros IM et al (2003) Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors. J Clin Oncol 21:4228–4234. doi:10.1200/JCO.2003.10.168
Kerbl R, Urban CE, Ladenstein R et al (1997) Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce “overdiagnosis” and to detect cases with “unfavorable” biologic features. Med Pediatr Oncol 29:1–10. doi:10.1002/(SICI)1096-911X(199707)29:1<1::AID-MPO1>3.0.CO;2-J
Suita S, Zaizen Y, Sera Y et al (1996) Mass screening for neuroblastoma: quo vadis? A 9-year experience from the Pediatric Oncology Study Group of the Kyushu area in Japan. J Pediatr Surg 31:555–558. doi:10.1016/S0022-3468(96)90495-9
Anonymous (1999) Report of the 1998 consensus conference on neuroblastoma screening. Med Pediatr Oncol 33:357–359. doi:10.1002/(SICI)1096-911X(199910)33:4<357::AID-MPO2>3.0.CO;2-A
Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369:2106–2120. doi:10.1016/S0140-6736(07)60983-0
Anonymous (1999) In: Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young J, Bunin GR (eds) Cancer incidence and survival among children and adolescents: United States, SEER Program 1975–1995. National Cancer Institute, Bethesda
French AE, Grant R, Weitzman S et al (2003) Folic acid food fortification is associated with a decline in neuroblastoma. Clin Pharmacol Ther 74:288–294. doi:10.1016/S0009-9236(03)00200-5
Munzer C, Menegaux F, Lacour B et al (2008) Birth-related characteristics, congenital malformation, maternal reproductive history and neuroblastoma: the ESCALE study (SFCE). Int J Cancer 122:2315–2321. doi:10.1002/ijc.23301
Hamrick SE, Olshan AF, Neglia JP, Pollock BH (2001) Association of pregnancy history and birth characteristics with neuroblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. Paediatr Perinat Epidemiol 15:328–337. doi:10.1046/j.1365-3016.2001.0376a.x
Schuz J, Kaletsch U, Meinert R, Kaatsch P, Spix C, Michaelis J (2001) Risk factors for neuroblastoma at different stages of disease. Results from a population-based case–control study in Germany. J Clin Epidemiol 54:702–709. doi:10.1016/S0895-4356(00)00339-5
Neglia JP, Smithson WA, Gunderson P, King FL, Singher LJ, Robison LL (1988) Prenatal and perinatal risk factors for neuroblastoma. A case–control study. Cancer 61:2202–2206. doi:10.1002/1097-0142(19880601)61:11<2202::AID-CNCR2820611113>3.0.CO;2-7
Chow EJ, Friedman DL, Mueller BA (2007) Maternal and perinatal characteristics in relation to neuroblastoma. Cancer 109:983–992. doi:10.1002/cncr.22486
Mili F, Khoury MJ, Flanders WD, Greenberg RS (1993) Risk of childhood cancer for infants with birth defects. I. A record-linkage study, Atlanta, Georgia, 1968–1988. Am J Epidemiol 137:629–638
Altmann AE, Halliday JL, Giles GG (1998) Associations between congenital malformations and childhood cancer. A register-based case–control study. Br J Cancer 78:1244–1249
Merks JH, Caron HN, Hennekam RC (2005) High incidence of malformation syndromes in a series of 1,073 children with cancer. Am J Med Genet A 134:132–143. doi:10.1002/ajmg.a.30603
Urayama KY, Von Behren J, Reynolds P (2007) Birth characteristics and risk of neuroblastoma in young children. Am J Epidemiol 165:486–495. doi:10.1093/aje/kwk041
Yeazel MW, Ross JA, Buckley JD, Woods WG, Ruccione K, Robison LL (1997) High birth weight and risk of specific childhood cancers: a report from the Children’s Cancer Group. J Pediatr 131:671–677. doi:10.1016/S0022-3476(97)70091-X
McCall EE, Olshan AF, Daniels JL (2005) Maternal hair dye use and risk of neuroblastoma in offspring. Cancer Causes Control 16:743–748. doi:10.1007/s10552-005-1229-y
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005) International classification of childhood cancer, third edition. Cancer 103:1457–1467. doi:10.1002/cncr.20910
McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS (2006) Birth weight, maternal weight and childhood leukaemia. Br J Cancer 94:1738–1744. doi:10.1038/sj.bjc.6603173
McLaughlin CC, Baptiste MS, Schymura MJ, Nasca PC, Zdeb MS (2006) Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 163:818–828. doi:10.1093/aje/kwj104
Martin JA, Hamilton BE, Ventura SJ, Menacker F, Park MM, Sutton PD (2002) Births: final data for 2001. Natl Vital Stat Rep 51:1–102
Rothman K, Greenland S (1998) Modern epidemiology. Lippincott Williams & Wilkins, Philidelphia
Khoury MJ, Flanders WD, James LM, Erickson JD (1989) Human teratogens, prenatal mortality, and selection bias. Am J Epidemiol 130:361–370
Cragan JD, Khoury MJ (2000) Effect of prenatal diagnosis on epidemiologic studies of birth defects. Epidemiology 11:695–699. doi:10.1097/00001648-200011000-00014
Kramer S, Ward E, Meadows AT, Malone KE (1987) Medical and drug risk factors associated with neuroblastoma: a case–control study. J Natl Cancer Inst 78:797–804
Acharya S, Jayabose S, Kogan SJ et al (1997) Prenatally diagnosed neuroblastoma. Cancer 80:304–310. doi:10.1002/(SICI)1097-0142(19970715)80:2<304::AID-CNCR19>3.0.CO;2-Y
Newton ER, Louis F, Dalton ME, Feingold M (1985) Fetal neuroblastoma and catecholamine-induced maternal hypertension. Obstet Gynecol 65:49S–52S
Schwartzbaum JA (1992) Influence of the mother’s prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol 135:1358–1367
Schuz J, Weihkopf T, Kaatsch P (2007) Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr 166:433–441. doi:10.1007/s00431-006-0401-z
Bjorge T, Engeland A, Tretli S, Heuch I (2008) Birth and parental characteristics and risk of neuroblastoma in a population-based Norwegian cohort study. Br J Cancer 99:1165–1169
Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC (1996) Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 143:996–1001
Buck GM, Michalek AM, Chen CJ, Nasca PC, Baptiste MS (2001) Perinatal factors and risk of neuroblastoma. Paediatr Perinat Epidemiol 15:47–53. doi:10.1046/j.1365-3016.2001.00307.x
Bluhm E, McNeil DE, Cnattingius S, Gridley G, El GL, Fraumeni Jr JF (2008) Prenatal and perinatal risk factors for neuroblastoma. Int J Cancer 123:2885–2890
Langer T, Deeg KH, Hummer P, Paulides M, Beck JD, Klinge J (2007) Postnatal respiratory distress in a dichorial twin with congenital thoracic neuroblastoma after assisted reproduction by intracytoplasmatic sperm injection. Pediatr Blood Cancer 48:358–360. doi:10.1002/pbc.20936
Li AM, Chang J, Kumar A (2001) Neonatal neuroblastoma presenting with respiratory distress. J Paediatr Child Health 37:203–205. doi:10.1046/j.1440-1754.2001.00590.x
Halperin DS, Oberhansli I, Siegrist CA et al (1984) Intrathoracic neuroblastoma presenting with neonatal cardiorespiratory distress. Chest 85:822–823. doi:10.1378/chest.85.6.822
Hermansen CL, Lorah KN (2007) Respiratory distress in the newborn. Am Fam Physician 76:987–994
Raabe EH, Laudenslager M, Winter C et al (2008) Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene 27:469–476. doi:10.1038/sj.onc.1210659
Roohan PJ, Josberger RE, Acar J, Dabir P, Feder HM, Gagliano PJ (2003) Validation of birth certificate data in New York State. J Community Health 28:335–346. doi:10.1023/A:1025492512915
Reichman NE, Schwartz-Soicher O (2007) Accuracy of birth certificate data by risk factors and outcomes: analysis of data from New Jersey. Am J Obstet Gynecol 197:32–38. doi:10.1016/j.ajog.2007.02.026
Schuz J, Kaatsch P, Kaletsch U, Meinert R, Michaelis J (1999) Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 28:631–639. doi:10.1093/ije/28.4.631
Lee J, Chia KS, Cheung KH, Chia SE, Lee HP (2004) Birthweight and the risk of early childhood cancer among Chinese in Singapore. Int J Cancer 110:465–467. doi:10.1002/ijc.20159
Daling JR, Starzyk P, Olshan AF, Weiss NS (1984) Birth weight and the incidence of childhood cancer. J Natl Cancer Inst 72:1039–1041
Johnson CC, Spitz MR (1985) Neuroblastoma: case–control analysis of birth characteristics. J Natl Cancer Inst 74:789–792
Suminoe A, Matsuzaki A, Kinukawa N et al (1999) Rapid somatic growth after birth in children with neuroblastoma: a survey of 1718 patients with childhood cancer in Kyushu-Okinawa district. J Pediatr 134:178–184. doi:10.1016/S0022-3476(99)70412-9
Smulevich VB, Solionova LG, Belyakova SV (1999) Parental occupation and other factors and cancer risk in children: I. Study methodology and non-occupational factors. Int J Cancer 83:712–717. doi:10.1002/(SICI)1097-0215(19991210)83:6<712::AID-IJC2>3.0.CO;2-D
Altieri A, Castro F, Bermejo JL, Hemminki K (2006) Association between number of siblings and nervous system tumors suggests an infectious etiology. Neurology 67:1979–1983. doi:10.1212/01.wnl.0000247036.98444.38
Menegaux F, Olshan AF, Neglia JP, Pollock BH, Bondy ML (2004) Day care, childhood infections, and risk of neuroblastoma. Am J Epidemiol 159:843–851. doi:10.1093/aje/kwh111
Acknowledgements
Partial support for authors was received from the Centers for Disease Control and Prevention’s National Program of Cancer Registries by cooperative agreement U58DP000783-01 awarded to the New York State Department of Health. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McLaughlin, C.C., Baptiste, M.S., Schymura, M.J. et al. Perinatal risk factors for neuroblastoma. Cancer Causes Control 20, 289–301 (2009). https://doi.org/10.1007/s10552-008-9243-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9243-5